Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein

Journal of Experimental Medicine

Volumn 187, Issue 7, 1998, Pages 973-984

  Carrasco, Daniel ^a,c   Cheng, Janet ^a   Lewin, Anne ^a   Warr, Glenn ^a   Yang, Hyekyung ^a   Rizzo, Cheryl ^a   Rosas, Fabio ^b   Snapper, Clifford ^b   Bravo, Rodrigo ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW HYPOPLASIA; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXTRAMEDULLARY HEMATOPOIESIS; HEMATOPOIESIS; LYMPHOID HYPERPLASIA; MOUSE; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSACTIVATION;

ANIMALS; B-LYMPHOCYTES; BONE MARROW; CELL LINE; DNA-BINDING PROTEINS; FLOW CYTOMETRY; HEMATOPOIESIS; LISTERIA MONOCYTOGENES; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; PSEUDOLYMPHOMA; SEQUENCE DELETION; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0032489825     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.7.973     Document Type: Article

References (57)

1. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-κB/Rel transcription factor and κB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
2. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
3. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455.
4. Finco, T.S., and A.S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 3:263-272.
5. Kopp, E.B., and S. Ghosh. 1995. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:1-27.
6. Miyamoto, S., and I.M. Verma. 1995. Rel/NF-κB story. Adv. Cancer Res. 66:255-292.
7. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell. 80:529-532.
8. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
9. Baeuerle, P.A., and D. Baltimore. 1996. NF-κB: ten years after. Cell. 87:13-20.
10. Baldwin, A.S. 1996. The NF-κB and Iκβ proteins, new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
11. Carrasco, D., R.-P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development. 118:1221-1231.
12. Carrasco, D., F. Weih, and R. Bravo. 1994. Developmental expression of the mouse c-rel protooncogene in hematopoietic organs. Development. 120:2991-3004.
13. Attar, R., J. Caamaño, D. Carrasco, V. Iotsova, H. Ishikawa, R.-P. Ryseck, F. Weih, and R. Bravo. 1997. Genetic approaches to study Rel/NF-κB/ IκB function in mice. Semin. Cancer Biol. 8:93-101
14. Whiteside, S.T., J.-C. Epinat, N.R. Rice, and A. Israël. 1997. I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO (Eur. Mol. Biol. Organ.) J. 16:1413-1426.
15. Chen, Z.J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of the IκBα by a novel ubiquitination-dependent protein kinase activity. Cell. 84:853-862.
16. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
17. Bose, H.R. 1992. The Rel family: models for transcriptional regulation and oncogenic transformation. Biochim. Biophys. Acta 1114:1-17.
18. Kabrun, N., and P.J. Enrietto. 1994. The Rel family of proteins in oncogenesis and differentiation. Semin. Cancer Biol. 5: 103-112.
19. Gilmore, T.D. 1992. Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surv. 15:69-87.
20. Gilmore, T.D., M. Koedood, K.A. Piffat, and D.W. White. 1996. Rel/NF-κB/IκB proteins and cancer. Oncogene. 13: 1367-1378.
21. Köntgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
22. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigonadis, J.-P.Y. Scheerlinck, and R.J. Grumont. 1996. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA. 93:3405-3409.
23. Grigoriadis, G., Y. Zhan, R.J. Grumont, D. Metcalf, E. Handman, C. Cheers, and S. Gerondakis. 1996. The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO (Eur. Mol. Biol. Organ.) J. 15:7099-7107.
24. Bull, P., K.L. Morley, M.F. Hoekstra, T. Hunter, and I.M. Verma. 1990. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol. Cell. Biol. 10:5473-5485.
25. Tybulewicz, V.L.J., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 65:1153-1163.
26. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multi-organ inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell. 80:331-340.
27. Matsumoto, M., S. Mariathasan, M.H. Nahm, F. Baranyay, J.J. Peschon, and D.C. Chaplin. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science. 271:1289-1291.
28. Coligan, J.E., A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober. 1992. Isolation and fractionation of mononuclear cell populations. In Current Protocols in Immunology. J.W. Sons, editor. Greene Publishing Associates & Wiley-Interscience, New York. 3.0.1-3.0.5.
29. Snapper, C.M., F.R. Rosas, P. Zelazowski, M.A. Moorman, M.R. Kehry, R. Bravo, and F. Weih. 1996. B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 184:1537-1541.
30. Ahmed, R., A. Salmi, L.D. Butler, J.M. Chiller, and M.B.A. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. J. Exp. Med. 60:521-540.
31. Grove, R., N. Allegretto, P. Kiener, and G. Warr. 1990. Lipopolysaccharide alters phosphatidylcholine metabolism in elicited peritoneal macrophages. J. Leukocyte Biol. 48:38-42.
32. Johnson, K.J., M. Glovsky, and D. Schrier. 1984. Pulmonary granulomatous vasculitis: pulmonary granulomatous vasculitis induced in rats by treatment with glucan. Am. J. Pathol. 114: 515-516.
33. Ding, A.H., C.F. Nathan, and D.J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
34. Carrasco, D., C.A. Rizzo, K. Dorfman, and K. Bravo. 1996. The v-rel oncogene promotes malignant T-cell leukemia/ lymphoma in transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 15:3640-3650.
35. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene. 9:3289-3297.
36. Dobrzanski, P., R.-P. Ryseck, and R. Bravo. 1993. Both N-and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol. Cell. Biol. 13:1572-1582.
37. Gorman, C., L.F. Moffat, and B. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
38. Ryseck, R.-P., H. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674-684.
39. Wang, C.-Y., M.W. Mayo, and A.S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:784-787.
40. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:787-789.
41. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274: 782-784.
42. Kaufmann, S.H.E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
43. Nathan, C.F., and J.B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Biol. 3: 65-70.
44. Gordon, S., S. Clarke, D. Greaves, and A. Doyle. 1995. Molecular immunobiology of macrophages: recent progress. Curr. Opin. Immunol. 7:24-33.
45. Lehmann-Grube, F., D. Moskophidis, and J. Löhler. 1988. Recovery from acute virus infection. Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice. Ann. NY Acad. Sci. 532: 238-256.
46. Richardson, P.M., and T.D. Gilmore. 1991. vRel is an inactive member of the Rel family of transcriptional activating proteins. J. Virol. 65:3122-3130.
47. Schmitz, M.L., and P.A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO (Eur. Mol. Biol. Organ.) J. 10:3805-3817.
48. Tarlinton, D. 1997. Germinal centers: a second childhood for lymphocytes. Curr. Biol. 7:R155-R159.
49. Thorbecke, G.J., A.R. Amin, and V.K. Tsiagbe. 1994. Biology of germinal centers in lymphoid tissue. FASEB J. 8: 832-840.
50. H transcription and Ig class switching. J. Immunol. 154:3133-3139.
51. Neri, A., N.S. Fracciolla, E. Rosecetti, S. Garatti, D. Trecca, A. Bolatini, B. Perletti, L. Bardini, A.T. Maiolo, and E. Berti 1995. Molecular analysis of cutaneous B-and T-cell lymphomas. Blood. 86:3160-3172.
52. Chang, C.-C., J. Zhang, L. Lombardi, A. Neri, and R. Dalla-Favera. 1995. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol. Cell. Biol. 15:5180-5187.
53. Lu, D., J.D. Thompson, G.K. Gorski, N.R. Rice, M.G. Mayer, and J.J. Yunis. 1991. Alterations at the rel locus in human lymphoma. Oncogene. 6:1235-1241.
54. Cacalano, G., J. Lee, K. Kikly, A.M. Ryan, S. Pitts-Meek, B. Hultgren, W.I. Wood, and M.W. Moore. 1994. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science. 265:682-684.
55. Dranoff, G., A.D. Crawford, M. Sadelain, B. Ream, A. Rashid, R.T. Bronson, G.R. Dickersin, C.J. Bachurski, E.L. Mark, J.A. Whitsett, and R.C. Mulligan. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 264:713-716.
56. Ishikawa, H., D. Carrasco, E. Claudio, R-F. Ryseck, and R. Bravo. 1997. Gastric hyperplasia and increased proliterative response of lymphocytes in mice lacking the COOH-terminal ankirin domain of NF-κB2. J. Exp. Med. 186:999-1014.
57. Iotsova, V., J. Caamaño, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 1285-1289.